Salix Pharmaceuticals (SLXP) Stock Pummeled on Earnings, Guidance

Shares of the Salix Pharmaceuticals Inc. (SLXP) were down -50.80 or -36.67 percent to $87.75 per share in Friday’s premarket after the company announced lower than expected earnings and lowered its full year forecast yesterday after the market close. Salix Pharmaceutical stock closed at $138.55, off -0.95 or -0.68 percent in Thursday’s regular trading session. Read the full article... Read the rest of Salix Pharmaceuticals (SLXP) Stock Pummeled on Earnings, Guidance at InvestorGuide.com .